Showing results (271-280 of 300) with videos related to

Sort By:
Pageof 30
Trials|February 29, 2024
A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in IndiaSundus Shafat Ahmad, Reena Verma, Robert J Commons, et al.
BMC Medicine|March 30, 2019
Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology dataPaul Turner, Andrew Fox-Lewis, Poojan Shrestha, et al.
BMC Medicine|October 26, 2016
Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and NigerLise Denoeud-Ndam, Alassane Dicko, Elisabeth Baudin, et al.
The Journal of Biological Chemistry|January 21, 2011
Structural basis for selective small molecule kinase inhibition of activated c-MetKeith W Rickert, Sangita B Patel, Timothy J Allison, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2013
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting toolCharles J Woodrow, Sabina Dahlström, Richard Cooksey, et al.
BMJ Global Health|December 20, 2023
Safety and efficacy of primaquine in patients with <i>Plasmodium vivax</i> malaria from South Asia: a systematic review and individual patient data meta-analysisReena Verma, Robert J Commons, Apoorv Gupta, et al.
Plos Medicine|January 11, 2017
Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-AnalysisRichard M Hoglund, Lesley Workman, Michael D Edstein, et al.
Malaria Journal|December 14, 2011
Poor quality vital anti-malarials in Africa - an urgent neglected public health priorityPaul N Newton, Michael D Green, Dallas C Mildenhall, et al.
Journal of Medicinal Chemistry|February 6, 2013
Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-MetAlan B Northrup, Matthew H Katcher, Michael D Altman, et al.
BMC Medicine|February 27, 2020
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient dataMichael T Bretscher, Prabin Dahal, Jamie Griffin, et al.
Pageof 30